PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Hoth Therapeutics, Inc.
Filed: April 26, 2021
Period of Report: April 26, 2021
Accession Number: 0001213900-21-022924

View Document ↗ View on SEC.gov ↗